Developed a proprietary biomarker discovery platform (MVA) to identify antibody signatures for a variety of diseases. MVA makes this possible through a unique combination of phage display screening, next-generation sequencing, and big data analytics. IPDx applies MVA to develop diagnostics for a variety of diseases and collaborates with researchers interested in biomarker discovery, vaccine development, and multiplex diagnostic panel development.
Get a demo today to see profiles of Spineology plus 6164 other startups.
Trusted By The Companies Pioneering What’s Next
17011 Beach Blvd, Suite 500 Huntington Beach, CA 92647
714-847-3540© 2025 Life Science Intelligence, Inc., All Rights Reserved. | Privacy Policy